• Highly effective | • Bleeding side effects |
• Coitally independent | • Weight gaina |
• Possible to use without partner's knowledge | • Reduced bone density (temporary) |
• Lasts a full 3 months | • Not advised during early breastfeeding by WHO |
• 1-month grace period for reinjection | • Delayed return to fertility |
• Safe and suitable for nearly all women | • Higher initial blood dosage than needed for efficacy |
• Relatively low cost | • Requires repeated visits |
• Easy for providers | • System burden (eg, supply chain, staff time) |
• Somewhat easy and convenient for clients | • Provider bias (eg, reluctance to offer it to young women) |
• Amenable to community-based distribution | • Poor continuation |
| • Implicated for possible increased HIV risk |